Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
Songthong AP, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Songthong AP, et al. Among authors: kannarunimit d. Radiat Oncol. 2015 Aug 8;10:166. doi: 10.1186/s13014-015-0472-y. Radiat Oncol. 2015. PMID: 26253488 Free PMC article. Clinical Trial.
Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis.
Chitapanarux I, Tungkasamit T, Petsuksiri J, Kannarunimit D, Katanyoo K, Chakkabat C, Setakornnukul J, Wongsrita S, Jirawatwarakul N, Lertbusayanukul C, Sripan P, Traisathit P. Chitapanarux I, et al. Among authors: kannarunimit d. Support Care Cancer. 2018 Mar;26(3):879-886. doi: 10.1007/s00520-017-3904-4. Epub 2017 Sep 23. Support Care Cancer. 2018. PMID: 28942587 Clinical Trial.
A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C, Prayongrat A, Kannarunimit D, Chakkabat C, Netsawang B, Kitpanit S. Lertbutsayanukul C, et al. Among authors: kannarunimit d. Strahlenther Onkol. 2018 May;194(5):375-385. doi: 10.1007/s00066-017-1251-5. Epub 2018 Jan 4. Strahlenther Onkol. 2018. PMID: 29302704 Clinical Trial. English.
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C, Kitpanit S, Prayongrat A, Kannarunimit D, Netsawang B, Chakkabat C. Lertbutsayanukul C, et al. Among authors: kannarunimit d. J Radiat Res. 2018 Jul 1;59(4):446-455. doi: 10.1093/jrr/rry036. J Radiat Res. 2018. PMID: 29750261 Free PMC article. Clinical Trial.
Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.
Kitpanit S, Jittapiromsak N, Sriyook A, Prayongrat A, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Kitpanit S, et al. Among authors: kannarunimit d. Jpn J Clin Oncol. 2019 Dec 27;49(12):1100-1113. doi: 10.1093/jjco/hyz109. Jpn J Clin Oncol. 2019. PMID: 31334768
28 results